For the Inventor, By the Inventor

Enter assignee name

Foster City, CA, United States of America

Gilead Pharmasset LLC

USPTO Granted Patents = 81

CIPO Patents = 6

EPO Patents = 45

Trademarks = 3

Forward Citations = 1,907

Loading Chart...

Loading Chart...

119 inventors (with patents filed for the assignee):

Michael Joseph Sofia (31 out of 34 patents)

Jinfa Du (23 out of 34 patents)

Peiyuan Wang (21 out of 47 patents)

4. John O Link (19 out of 99 patents)

5. Ganapati Reddy Pamulapati (18 out of 19 patents)

6. Jeromy J Cottell (17 out of 60 patents)

7. Darryl Kato (15 out of 46 patents)

8. Elizabeth M Bacon (15 out of 48 patents)

9. James G Taylor (15 out of 95 patents)

10. Bruce Ross (15 out of 18 patents)

11. Dhanapalan Nagarathnam (15 out of 61 patents)

12. Suguna Rachakonda (14 out of 16 patents)

13. Teresa Alejandra Trejo Martin (13 out of 30 patents)

14. Evan S Krygowski (13 out of 17 patents)

15. Byoung-Kwon Chun (13 out of 27 patents)

Core Competencies:

Antiviral Compounds

Hepatitis C Virus

Nucleoside Phosphoramidates

Combination Formulation

Solid Forms

Modified Nucleosides

Fluorinated Nucleoside Analogues

Nucleoside Phosphoramidate Prodrugs

2'-Fluoro-2'-Alkyl-Substituted

Synthesis of Antiviral Compound

2',4'-Substituted Nucleosides

2'-Spiro-Nucleosides

81 patents: Sort by Forward Citations

1. 11203599 - Solid forms of an antiviral compound (2021-12-21),

2. 11192875 - Processes for preparing antiviral compounds (2021-12-07),

3. 11116783 - Combination formulation of two antiviral compounds (2021-09-14),

4. 10912814 - Combination formulation of three antiviral compounds (2021-02-09),

5. 10807990 - Antiviral compounds (2020-10-20),

6. 10800789 - Antiviral compounds (2020-10-13),

7. 10604530 - Solid forms of an antiviral compound (2020-03-31),

8. 10603318 - Inhibitors of hepatitis C virus (2020-03-31),

9. 10584109 - Processes for preparing antiviral compounds (2020-03-10),

10. 10577359 - Preparation of 2'-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives (2020-03-03),

11. 10456414 - Methods for treating HCV (2019-10-29),

12. 10344019 - Antiviral compounds (2019-07-09),

13. 10335409 - Inhibitors of hepatitis C virus (2019-07-02),

14. 10287311 - Modified fluorinated nucleoside analogues (2019-05-14),

15. 10183037 - Nucleoside phosphoramidate prodrugs (2019-01-22),

Gilead Pharmasset LLC is a leading biopharmaceutical company specializing in the development and commercialization of innovative therapeutics to address unmet medical needs. With a strong focus on antiviral drugs, the company aims to improve patient outcomes in areas such as HIV/AIDS, viral hepatitis, and respiratory diseases. Through dedicated research and strategic partnerships, Gilead Pharmasset LLC strives to bring life-saving treatments to millions of people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

81 Patents

#8 in Foster City, CA

#1,046 in California

#4,421 in US

#9,086 in the World

Foster City, CA, United States of America

Gilead Pharmasset LLC

Forward Citations = 1,907

119 inventors:

Michael Joseph Sofia (31 out of 34 patents)

Jinfa Du (23 out of 34 patents)

Peiyuan Wang (21 out of 47 patents)

4. John O Link (19 out of 99 patents)

5. Ganapati Reddy Pamulapati (18 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…